Please use this identifier to cite or link to this item:
|Title:||Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities|
Doheny, Kimberly F.
Mingroni-Netto, Regina C.
Kim, Chong A.
Perez, Ana B. A. [UNIFESP]
Melaragno, Maria I. [UNIFESP]
Meloni, Vera A.
Bjornsson, Hans T.
|Publisher:||Nature Publishing Group|
|Citation:||European Journal Of Human Genetics. London, v. 25, n. 12, p. 1335-1344, 2017.|
|Abstract:||Kabuki syndrome is a monogenic disorder caused by loss of function variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched normal controls, regardless of whether they carry a variant in KMT2A or KMT2D or not. Furthermore, we observed characteristic global abnormalities of DNA methylation that distinguished patients with a loss of function variant in KMT2D or missense or splice site variants in either KMT2D or KMT2A from normal controls. Our results provide new insights into the relationship of genotype to epigenotype and phenotype and indicate cross-talk between histone and DNA methylation machineries exposed by inborn errors of the epigenetic apparatus.|
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.